Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of the Safety and Pharmacokinetics of 552-02 Following 14 Days of Dosing By Inhalation in Patients With Cystic Fibrosis

NCT00274313 is registered in ClinicalTrials.gov with Parion Sciences as lead sponsor.

NCT NCT00274313
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00274313 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of the Safety and Pharmacokinetics of 552-02 Following 14 Days of Dosing By Inhalation in Patients With Cystic Fibrosis
Lead sponsor
Parion Sciences
Phase
Phase 1/2
Overall status
Completed
Start date
January 31, 2006
Completion date
August 31, 2006
Enrollment
40
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis